Biote Corp. Class A Common Stock (BTMD) Stock Price

BTMDStock

$1.58−51.24%52W

Market Cap$53.56M

P/E1.96x

PEG Ratio—

Div yield—

Beta1.67

BTMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-35.40%

Price vs S&P 500 (4W)-32.96%

VGM Score51.83

P/E Ratio (Annual)1.96x

P/CF (Annual)1.51x

Book Value / Share (Quarterly)$1.29

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)5.22%

Cash Flow / Share (Quarterly)$0.88

Price vs S&P 500 (YTD)-51.57%

Gross Margin (TTM)70.12%

Net Profit Margin (TTM)8.29%

EPS (TTM)$0.44

10-Day Avg Trading Volume0.37M

EPS Excl Extra (TTM)$0.44

Revenue Growth (5Y)10.51%

EPS (Annual)$0.74

ROI (Annual)79.32%

Gross Margin (Annual)71.46%

Net Profit Margin (5Y Avg)8.05%

Cash / Share (Quarterly)$0.18

P/E Basic Excl Extra (TTM)3.39x

Revenue Growth QoQ (YoY)-8.28%

EPS Growth (5Y)-26.84%

P/E Normalized (Annual)1.96x

ROA (Last FY)25.13%

Revenue Growth TTM (YoY)-5.63%

EBITD / Share (TTM)$0.88

Operating Margin (TTM)15.43%

Cash Flow / Share (Annual)$0.92

P/B Ratio4.95x

P/B Ratio (Quarterly)36.65x

Net Income / Employee (Annual)$121,300

EV / Revenue (TTM)0.81x

Net Interest Coverage (TTM)4.43x

ROA (TTM)15.12%

EPS Growth QoQ (YoY)-85.47%

EV / EBITDA (TTM)4.94x

EPS Incl Extra (Annual)$0.74

Current Ratio (Annual)1.22x

Quick Ratio (Quarterly)0.45x

3-Month Avg Trading Volume0.28M

52-Week Price Return-51.24%

EV / Free Cash Flow (Annual)5.41x

P/E Incl Extra (TTM)3.39x

Revenue / Employee (TTM)$843,800

Tangible BV / Share (Quarterly)$0.71

P/S Ratio (Annual)0.28x

Asset Turnover (Annual)1.79x

52-Week High$3.62

Operating Margin (5Y Avg)7.54%

EPS Excl Extra (Annual)$0.74

CapEx CAGR (5Y)37.63%

26-Week Price Return-24.15%

Quick Ratio (Annual)0.71x

13-Week Price Return-24.15%

Total Debt / Equity (Annual)9.02x

Current Ratio (Quarterly)1.29x

Enterprise Value$153.33M

Revenue / Share Growth (5Y)-17.89%

Asset Turnover (TTM)1.82x

Revenue / Employee (Annual)$862,000

Inventory Turnover (Annual)3.24x

Pretax Margin (Annual)19.55%

Cash / Share (Annual)$0.79

3-Month Return Std Dev99.72%

Gross Margin (5Y Avg)68.53%

Net Income / Employee (TTM)$70,000

EBITDA CAGR (5Y)2.68%

EBITDA Interim CAGR (5Y)-17.70%

ROE (Last FY)795.12%

Net Interest Coverage (Annual)3.34x

EPS Basic Excl Extra (Annual)$0.74

P/FCF (TTM)2.00x

Receivables Turnover (TTM)24.82x

EV / Free Cash Flow (TTM)5.80x

Total Debt / Equity (Quarterly)3.35x

EPS Incl Extra (TTM)$0.44

Receivables Turnover (Annual)26.51x

ROI (TTM)-1.69%

P/S Ratio (TTM)0.28x

Pretax Margin (5Y Avg)8.93%

Revenue / Share (Annual)$5.24

Tangible BV / Share (Annual)$-5.13

Forward P/E8.65x

Free OCF CAGR (5Y)2.50%

Price vs S&P 500 (52W)-69.55%

P/E Ratio (TTM)3.39x

EPS Growth TTM (YoY)-14.64%

Year-to-Date Return-39.62%

5-Day Price Return20.77%

EPS Normalized (Annual)$0.74

ROA (5Y Avg)17.80%

Net Profit Margin (Annual)14.07%

Month-to-Date Return-30.22%

Cash Flow / Share (TTM)$0.00

EBITD / Share (Annual)$1.02

EPS Growth (3Y)-71.38%

Operating Margin (Annual)18.50%

LT Debt / Equity (Annual)7.80x

P/CF (TTM)1.62x

P/E Excl Extra (TTM)3.39x

LT Debt / Equity (Quarterly)2.88x

EPS Basic Excl Extra (TTM)$0.44

P/TBV (Quarterly)66.46x

Inventory Turnover (TTM)3.37x

Pretax Margin (TTM)12.47%

Book Value / Share (Annual)$-4.60

Price vs S&P 500 (13W)-26.95%

Net Margin Growth (5Y)-10.89%

Beta1.67x

P/FCF (Annual)1.87x

Revenue / Share (TTM)$5.23

ROE (TTM)-1.60%

52-Week Low$1.27

vGradeA

gGradeD

mGradeD

vgmGradeC

BTMD Earnings Surprise History

Q2 250.16est. 0.13

Q3 250.18est. 0.12

Q4 250.07est. 0.10

Q1 260.08est. 0.08

Q2 260.04est. 0.03

BTMD Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.58
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$44.81
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	F	$5.54
TRLVTrulieve Cannabis Corp.	B	C	A	$11.32
CRONCronos Group Inc. Common Share	C	B	B	$3.51
GLASGlass House Brands Inc.	C	C	C	$10.13
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.88
CGCCanopy Growth Corporation Common Shares	B	C	C	$1.07
SNDLSundial Growers Inc. Common Shares	A	C	C	$1.37
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.27
USNAUSANA Health Sciences Inc	B	D	D	$13.78
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.97
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$10.05
NAIINatural Alternatives International Inc.	A	C	D	$2.17
MTEXMannatech Inc.	B	D	C	$6.45
BONBon Natural Life Limited Class A Ordinary Shares	B	D	D	$1.14
AKANAkanda Corp. Common Shares	C	F	F	$4.95
IMCCIM Cannabis Corp. Common Shares	A	B	F	$0.11
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	F	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	D	$23.68

About Biote Corp. Class A Common Stock

Biote Corp provides hormone optimization solutions and operational support to licensed practitioners. The company supplies practitioners with products and tools to offer personalized hormone therapy programs to patients. Biote generates revenue through operations in the United States and international markets.